Conference Support: The 13th International Drug Delivery Symposium

会议支持：第13届国际药物递送研讨会

• 批准号: 7267570
• 负责人: DAVID W GRAINGER
• 金额: $ 1.1万
• 依托单位: UNIVERSITY OF UTAH
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-02-23 至 2008-01-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7267570
• 关键词: Address; Area; Award; Biocompatible Materials; Biomedical Engineering; Biotechnology; Characteristics; Cities; Class; Clinical; Disease; Drug Delivery Systems; Drug Formulations; Faculty; Gender; Gene Delivery; Image; International; Leadership; Molecular; Oral; Participant; Penetration; Persons; Pharmaceutical Preparations; Pharmacologic Substance; Population; Research; Research Personnel; Scientist; Sodium Chloride; Solutions; Students; Thinking; Tissue Engineering; Tissues; Translational Research; Travel; Treatment Efficacy; Underrepresented Minority; Work; clinical application; cost; design; fundamental research; novel; posters; programs; symposium

DESCRIPTION (provided by applicant): This proposal by the Program Co-Chair (as PI) seeks support of selected junior and protected-class podium speakers, and 3 graduate student poster research presentation awards at the Thirteenth International Symposium on Recent Advances in Drug Delivery Systems, Salt Lake City, UT, February 26-28, 2007. The general theme of the 2007 technical drug delivery conference is centered on "overcoming long-standing barriers", more specifically focused on addressing molecular, cellular and tissue barriers to effective drug targeting, penetration, formulation, and efficacy. The program design maintains its highly regarded tradition in assembling oral sessions comprising world-renowned pharmaceutical scientists, bioengineers, industrial scientists, and clinicians all seeking solutions to compelling drug delivery problems. Overall specific aims in producing this meeting are to: 1) Provide a rich, diverse scientific program focusing on both fundamental and clinical phenomena that limit drug therapeutic efficacy in several important disease contexts (i.e., hurdles of translational research), as well as key areas of biotechnology where investigators are proposing solutions to drug delivery, imaging, tissue engineering problems; 2) Gather a group of presenters and participants comprising widely acknowledged thought-leaders as well as younger, aggressive, and vibrant faculty and research trainees already noted for novel and quality work. Speakers and session chairs will represent both academic and commercial drug delivery efforts: perspectives and leadership from both fundamental research and clinical applications. The program is already mature and detailed herein, including persons from underrepresented scientific groups. Emphasis will be placed on supporting the more junior participants and under-represented populations involved in these areas. This group will similarly represent the gender diversity characteristic of faculty working in these areas; 3) Facilitate interactions between junior and under-represented minority scientists and faculty working in the formulation, biotechnology, gene delivery, biomaterials, drug targeting, bio-conjugation and imaging areas with prominent senior and international investigators in the field. Support is requested both for selected speaker participation costs and 3 junior scientist poster travel awards.

描述（由申请人提供）：该计划联合主席（作为PI）的这一提案寻求支持选定的初级和受保护的级级扬声器，以及在第十三届国际毒品交付系统进步的国际进展研讨会上，在盐湖城市的最新进展中，在盐湖城，2007年2月26日至28日，在2007年级别的技术中，是2007年的技术，是在2007年的技术中。致力于解决有效的药物靶向，穿透，制剂和功效的分子，细胞和组织屏障。 该计划设计在组装包括世界知名的药物科学家，生物工程师，工业科学家和临床医生的口腔课程中保持了其备受推崇的传统，他们都在寻求解决方案来吸引药品交付问题。 举行本次会议的总体具体目的是：1）提供一项丰富的，多样化的科学计划，重点是基本和临床现象，这些计划限制了在几个重要疾病环境中的药物治疗功效（即转化研究的障碍），以及生物技术学的关键领域以及研究人员在其中提出了针对药物递送，想象，组织机构发动机问题的解决方案； 2）召集一群演讲者和参与者，包括广泛认可的思想领袖以及年轻，侵略性和充满活力的教师以及已经为新颖和优质工作所指出的研究学员。演讲者和会议主席将代表学术和商业药物提供工作：基础研究和临床应用的观点和领导。 该计划已经成熟并且在本文中详细介绍，包括来自代表性不足的科学团体的人。将重点放在支持这些领域中涉及的更初级参与者和代表性不足的人群上。 该小组将同样代表在这些领域工作的教师的性别多样性。 3）促进在制定，生物技术，基因递送，生物材料，药物靶向，生物缀合和成像领域的初级和代表性不足的少数族裔科学家和教师之间的相互作用。 请求支持选定的演讲者参与费用和3个初级科学家海报旅行奖。